to page content
to site navigation
The Resource Center has all the info you'll need From content to user feedback, the resource center has the information you need for every level of the entrepreneurial process.
A frequent buzzword in business these days is "Big Data." But how do investors and developers in the biotechnology industry make the best use of it?
Is venture capital still viable as a model for funding new bioscience research, products and businesses?
Healthcare entrepreneurs who have hit the intellectual property speed bump can relate to the appropriately named session, "Reducing Drag: New Approaches to IP Negotiation and Technology Licensing," at the Partnering for Cures conference earlier this week in New York City.
Investors in bioscience are looking not just for financial returns, but societal returns over the long haul in a global economy. And that will take collaborative efforts and a crowdsourcing of expertise as well as capital.
Want to get connected? Sign up to receive regular news, polls and updates from The Kauffman Foundation.